Zymeworks ZYME
NASDAQ ZYME
$29.42 -0.48 (-1.61%)
As of: Sep 4, 2026 · 1:35 PM EDT

Zymeworks (ZYME) Tax Provisions (2021 - 2026)

Zymeworks (ZYME) posted Tax Provisions of -$2.2 million for Q1 2026, down 711.48% sequentially from -$270000.0 in Q4 2025, and down 541.73% YoY from $496000.0 in Q1 2025.

Analysis

Zymeworks (ZYME) Tax Provisions (2021 - 2026) Analysis & Trends

Zymeworks has reported Tax Provisions for 6 years, with the latest figure at -$2.2 million in Q1 2026.

  • Quarterly Tax Provisions fell 541.73% year-over-year to -$2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.3 million (down 120.15% YoY) and the FY2025 annual result came in at $1.4 million, down 77.38% from the prior year.
  • Tax Provisions eased to -$2.2 million in Q1 2026 per ZYME's latest filing, from -$270000.0 in the prior quarter.
  • Over five years, Tax Provisions peaked at $11.0 million in Q4 2022 and troughed at -$4.7 million in Q4 2023.
  • A 5-year average of $917294.1 and a median of $75000.0 in 2024 frame the typical range for Tax Provisions.
  • The sharpest annual moves came in 2023 and 2026: Tax Provisions surged 18477.78% in 2023, then slumped 541.73% in 2026.
  • Over 5 years, Tax Provisions stood at $11.0 million in 2022, then sank by 142.91% to -$4.7 million in 2023, then surged by 221.03% to $5.7 million in 2024, then tumbled by 104.72% to -$270000.0 in 2025, then tumbled by 711.48% to -$2.2 million in 2026.
  • According to Business Quant data, Tax Provisions over the past three periods registered -$2.2 million, -$270000.0, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Vertex Pharmaceuticals 139.27 Bn 131.42 Bn 2.84 Bn 292.00 Mn
2 Regeneron Pharmaceuticals 85.55 Bn 77.56 Bn 3.93 Bn 230.90 Mn
3 Argenx Se 63.45 Bn 58.27 Bn 1.37 Bn -59.00 Mn
4 Moderna 57.73 Bn 52.59 Bn 52.00 Mn 15.00 Mn
5 Revolution Medicines 44.08 Bn 44.08 Bn - -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 75.45 Mn
7 Alnylam Pharmaceuticals 35.14 Bn 31.84 Bn 992.69 Mn 13.31 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - -
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn 1.90 Mn
10 Zymeworks 2.15 Bn 1.88 Bn - -273,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -273,000.00
Mar 31, 2026 -2.19 Mn
Dec 31, 2025 -270,000.00
Sep 30, 2025 1.34 Mn
Jun 30, 2025 -186,000.00
Mar 31, 2025 496,000.00
Dec 31, 2024 5.72 Mn
Sep 30, 2024 226,000.00
Jun 30, 2024 68,000.00
Mar 31, 2024 75,000.00
Dec 31, 2023 -4.72 Mn
Sep 30, 2023 1.11 Mn
Jun 30, 2023 1.65 Mn
Mar 31, 2023 1.39 Mn
Dec 31, 2022 11.01 Mn
Sep 30, 2022 -29,000.00
Jun 30, 2022 -9,000.00
Mar 31, 2022 -74,000.00
Dec 31, 2021 -1.37 Mn
Sep 30, 2021 764,000.00